Environmental and Epigenetic Modifiers of Susceptibility to Malignant Hyperthermia and Environmental Heat Stroke
恶性高热和环境中暑易感性的环境和表观遗传因素
基本信息
- 批准号:10606166
- 负责人:
- 金额:$ 79.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-28 至 2027-10-31
- 项目状态:未结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAgeBody TemperatureCaffeineCause of DeathCessation of lifeClinicalComplexCouplingDNA MethylationDantroleneDataDevelopmentDiseaseDominant-Negative MutationEnvironmentEpigenetic ProcessEventExerciseExhibitsExposure toFamilyFatty-acid synthaseFeedbackFemaleFeverFrequenciesGenesGeneticGlycolysisGoalsHeat Stress DisordersHeat StrokeHeritabilityHeterozygoteHumanIncidenceIndividualLife ExperienceMacromolecular ComplexesMalignant hyperpyrexia due to anesthesiaMeasuresMediatingMetabolicMilitary PersonnelModificationMolecularMusMutationOperative Surgical ProceduresOutcomePartner in relationshipPathogenicityPatientsPenetrancePredispositionPreventionProductionProteinsReportingRoleRyR1Ryanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSerumSeveritiesSex BiasSkeletal MuscleTeenagersTemperatureTestingThermogenesisVarianteffective therapyepigenomeinhibitorintergenerationalmalemetabolomicsmouse modelmuscle formnovel strategiesoffspringpediatric patientspreventprotein expressionresponsesexskeletal muscle metabolismtransgenerational epigenetic inheritancetransmission processyoung adult
项目摘要
Mutations in the skeletal muscle (SkM) sarcoplasmic reticulum (SR) Ca2+ release channel (Ryanodine Receptor
Type 1, RYR1), a component of the macromolecular complex that controls SkM excitation- contraction coupling
(ECC), are known genetic causes of Malignant Hyperthermia sensitivity (MHS) and Environmental Heat
Illness/Environmental Heat Stroke (EHI/EHS). MHS/EHS display incomplete penetrance, variable expressivity
and discordant inheritance. The reasons for this variability remain enigmatic. There are no effective treatments
for individuals with RYR1 pathogenic variants who experience life-threatening MHS/EHS episodes outside of
clinical settings (febrile pediatric patients, athletes, military personnel in hot environments).
Our goal is to develop approaches to prevent EHI-related deaths associated with RYR1 pathogenic variants.
We propose the existence of an environmentally sensitive, epigenetically regulated, feedback loop between
SkM and BAT that sensitizes MHS humans and mice to heat. Our specific hypotheses are: 1) Heat and
increased SkM activity drive metabolic and epigenetic changes in SkM and BAT to increase thermogenesis in
MHS mice. 2) Increased body temperature in MHS mice enhances SR Ca2+ leak, lactate production, AMPK
activation and metabolic changes in SkM, which, in turn, drive epigenetic modifications in SkM and BAT that
further enhance sensitivity to heat. 3) Heat-driven epigenetic changes are sex-biased and heritable and
contribute to discordance These hypotheses will be tested in 3 Specific Aims. Specific Aim 1: Define the roles
of heat, glycolysis, lactate, and adaptive thermogenesis in the enhanced sensitivity of MHS/EHS mice to heat.
Specific Aim 2: Define the role of RyR1 Ca2+ leak and AMPK activation in SKM on the enhanced sensitivity of
MHS mice to heat. Specific Aim 3: Determine if epigenetic changes driven by heat are heritable and sex biased.
Completion of these studies will elucidate fundamental molecular and epigenetic mechanisms that underlie
variability in EHS penetrance, expressivity, and genetic discordance, as well as provide new information on the
complex interplay of environment and genetics in these disorders. These data will lead to a new understanding
of the drivers of EHS episodes and, ultimately, to strategies for their prevention.
骨骼肌(SkM)肌浆网(SR)Ca 2+释放通道(Ryanodine受体)突变
1型,RYR 1),控制SkM兴奋-收缩偶联的大分子复合物的一种成分
(ECC)是恶性高热敏感性(MHS)和环境热的已知遗传原因
疾病/环境中暑(EHI/EHS)。MHS/EHS显示不完全的反射率,可变的表达率
和不和谐的遗传造成这种差异的原因仍然是个谜。没有有效的治疗方法
对于患有RYR 1致病性变异的个体,在非正常情况下发生危及生命的MHS/EHS事件,
临床环境(发热儿科患者、运动员、高温环境中的军事人员)。
我们的目标是开发预防与RYR 1致病性变异相关的EHI相关死亡的方法。
我们提出存在一个环境敏感,表观遗传调节,反馈回路之间
SkM和BAT使MHS人类和小鼠对热敏感。我们的具体假设是:1)热量和
增加的SkM活性驱动SkM和BAT中的代谢和表观遗传变化,
MHS小鼠。2)MHS小鼠体温升高可增强SR Ca 2+渗漏、乳酸产生和AMPK
SkM中的活化和代谢变化,这反过来又驱动SkM和BAT中的表观遗传修饰,
进一步增强对热的敏感性。3)热驱动的表观遗传变化具有性别偏见和遗传性,
这些假设将在3个特定目标中进行检验。具体目标1:确定角色
热,糖酵解,乳酸和适应性产热在MHS/EHS小鼠对热的敏感性增强。
具体目标2:确定SKM中RyR 1 Ca 2+泄漏和AMPK激活对增强的敏感性的作用。
MHS小鼠加热。具体目标3:确定由热驱动的表观遗传变化是否可遗传和性别偏见。
这些研究的完成将阐明基本的分子和表观遗传机制,
EHS的表达率,表达率和遗传不一致性的变异,以及提供关于
环境和遗传在这些疾病中的复杂相互作用。这些数据将导致一个新的认识
EHS事件的驱动因素,并最终制定预防策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES J DOWLING其他文献
JAMES J DOWLING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES J DOWLING', 18)}}的其他基金
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
AAV 介导的 PIK3C2B 基因敲低作为 X 连锁肌管肌病和脂肪肝的治疗策略
- 批准号:
10753786 - 财政年份:2023
- 资助金额:
$ 79.69万 - 项目类别:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
隐性 RYR1 相关肌病的病理生理学和治疗
- 批准号:
10405495 - 财政年份:2020
- 资助金额:
$ 79.69万 - 项目类别:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
隐性 RYR1 相关肌病的病理生理学和治疗
- 批准号:
10640863 - 财政年份:2020
- 资助金额:
$ 79.69万 - 项目类别:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
隐性 RYR1 相关肌病的病理生理学和治疗
- 批准号:
10224943 - 财政年份:2020
- 资助金额:
$ 79.69万 - 项目类别:
CCDC78 and the Pathogenesis of Centronuclear Myopathy
CCDC78 与中心核肌病的发病机制
- 批准号:
8768983 - 财政年份:2012
- 资助金额:
$ 79.69万 - 项目类别:
CCDC78 and the pathogenesis of centronuclear myopathy
CCDC78与中心核肌病的发病机制
- 批准号:
8288935 - 财政年份:2012
- 资助金额:
$ 79.69万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 79.69万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 79.69万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 79.69万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 79.69万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 79.69万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 79.69万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 79.69万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 79.69万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 79.69万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 79.69万 - 项目类别:
Studentship Programs














{{item.name}}会员




